Histogenics

About:

Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair.

Website: http://www.histogenics.com

Top Investors: Precigen, Sofinnova Investments, The Fintech Fund, Boston Millennia Partners, BioMed Ventures

Description:

Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Our first investigational product candidate, NeoCart®, leverages our platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.